Literature DB >> 4853603

Pharmacokinetics of practolol in renal failure.

G Bodem, H Grieser, M Eichelbaum, R Gugler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4853603     DOI： 10.1007/bf00560339

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  18 in total

1.  STUDIES WITH TRITIATED DIGOXIN IN RENAL FAILURE.

Authors:  J E DOHERTY; W H PERKINS; M C WILSON
Journal:  Am J Med       Date:  1964-10       Impact factor: 4.965

2.  Dose of gentamicin in patients with normal renal function and renal impairment.

Authors:  J C Gingell; P M Waterworth
Journal:  Br Med J       Date:  1968-04-06

3.  Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function.

Authors:  M M Reidenberg; I Odar-Cederlöf; C von Bahr; O Borgå; F Sjöqvist
Journal:  N Engl J Med       Date:  1971-07-29       Impact factor: 91.245

4.  Combined therapy with vasodilator drugs and beta-adrenergic blockade in hypertension. A comparative study of minoxidil and hydralazine.

Authors:  T B Gottlieb; F H Katz; C A Chidsey
Journal:  Circulation       Date:  1972-03       Impact factor: 29.690

5.  Simple fluorometric method for estimating practolol (1-(4-aminophenoxy)-3-isopropylaminopropan-2-0l) in blood and urine.

Authors:  G Bodem; C A Chidsey
Journal:  Clin Chem       Date:  1972-04       Impact factor: 8.327

6.  Pharmacokinetic studies of practolol, a beta adrenergic antagonist, in man.

Authors:  G Bodem; C A Chidsey
Journal:  Clin Pharmacol Ther       Date:  1973 Jan-Feb       Impact factor: 6.875

7.  Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases.

Authors:  F R Bühler; J H Laragh; L Baer; E D Vaughan; H R Brunner
Journal:  N Engl J Med       Date:  1972-12-14       Impact factor: 91.245

8.  Pharmacodynamics of propranolol in renal failure.

Authors:  F D Thompson; A M Joekes; D M Foulkes
Journal:  Br Med J       Date:  1972-05-20

9.  The effects of renal impairment, peritoneal dialysis, and hemodialysis on serum sodium colistimethate levels.

Authors:  N J Goodwin; E A Friedman
Journal:  Ann Intern Med       Date:  1968-05       Impact factor: 25.391

10.  An improved method of digoxin therapy.

Authors:  R W Jelliffe
Journal:  Ann Intern Med       Date:  1968-10       Impact factor: 25.391
View more
  9 in total

1.  Clinical pharmacokinetics of beta-adrenoreceptors blockers.

Authors:  G Johnsson; C G Regårdh
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 2.  Pharmacokinetic optimisation of therapy with beta-adrenergic blocking agents.

Authors:  W H Frishman; E J Lazar; G Gorodokin
Journal:  Clin Pharmacokinet       Date:  1991-04       Impact factor: 6.447

3.  Pharmacokinetics of acebutolol in patients with all grades of renal failure.

Authors:  A Roux; P Aubert; J Guedon; B Flouvat
Journal:  Eur J Clin Pharmacol       Date:  1980-05       Impact factor: 2.953

4.  Pharmacokinetics of atenolol in patients with renal impairment.

Authors:  J Sassard; N Pozet; J McAinsh; J Legheand; P Zech
Journal:  Eur J Clin Pharmacol       Date:  1977-11-14       Impact factor: 2.953

Review 5.  Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.

Authors:  G Johnsson; C G Regàrdh
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

6.  Pharmacokinetics of sotalol after chronic administration to patients with renal insufficiency.

Authors:  G Berglund; R Descamps; J A Thomis
Journal:  Eur J Clin Pharmacol       Date:  1980-10       Impact factor: 2.953

7.  Pharmacokinetic and pharmacodynamic properties of metoprolol in patients with impaired renal function.

Authors:  L Jordö; P O Attman; M Aurell; L Johansson; G Johnsson; C G Regårdh
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

8.  Differences in kinetic properties of drugs: implications as to the selection of a particular drug for use in patients with renal failure with special emphasis on antibiotics and beta-adrenoceptor blocking agents.

Authors:  J Fabre; H M Fox; P Dayer; L Balant
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447

9.  Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup.

Authors:  Josée Bouchard; Greene Shepherd; Robert S Hoffman; Sophie Gosselin; Darren M Roberts; Yi Li; Thomas D Nolin; Valéry Lavergne; Marc Ghannoum
Journal:  Crit Care       Date:  2021-06-10       Impact factor: 9.097
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.